Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis

<div>Survival (a) and incidence of acute exacerbation (AE) (b) in patients with idiopathic pulmonary fibrosis (IPF). Median survival time was 2079 days (a) and median interval from diagnosis to AE was 2707 days (b).</div>

Canadian Respiratory Journal

fig1

Figure 1

Figure 1: Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis 